Blood flow alterations in TNBS-induced colitis: role of endothelin receptors

Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]
M DenizH Kurtel

Abstract

The aim of the present study was to investigate the time dependent changes in hemodynamic parameters and to assess the role of endothelin (ET) receptors in trinitrobenzene sulfonic acid (TNBS) induced colitis. Inferior mesenteric artery (IMA) hemodynamics, myeloperoxidase activity (MPO) and damage scores were measured immediately or 1, 3, 5 and 14 days after colitis. Another group of rats received a nonselective ET receptor antagonist bosentan (30 mg/kg/day), ET-A receptor antagonist BQ485 (60 microg/rat/day) or ET-B receptor antagonist BQ788 (60 microg/rat/day) prior to and on the 1st, 2nd and 3rd days after TNBS administration. IMA flow significantly increased at 90 min followed by a substantial decrease through days 1-5. Tissue MPO activity and macroscopic damage score increased on 1st day after the induction of colitis and remained elevated 3, 5 and 14 days following colitis. Treatment with bosentan or ET-A receptor antagonist largely prevented the colitis-induced reduction in blood flow and tissue injury whereas ET-B receptor antagonist did not attenuate tissue injury or reductions in blood flow. Our results demonstrate that time-dependent abnormalities occur in IMA hemodynamics following TNBS administration. Our findings ...Continue Reading

Citations

Jul 27, 2006·Digestive Diseases and Sciences·Martin KruschewskiHeinz J Buhr
Jul 16, 2010·Canadian Journal of Physiology and Pharmacology·Rafaela Franco ClaudinoGiles Alexander Rae
Aug 30, 2008·Digestive Diseases and Sciences·Turhan DostMustafa Birincioglu
Feb 6, 2010·European Journal of Pharmacology·Susana Sánchez-FidalgoCatalina Alarcón de la Lastra
Mar 9, 2007·European Journal of Pharmacology·Marina Sánchez-HidalgoCatalina Alarcón de la Lastra
Feb 14, 2006·British Journal of Pharmacology·Antonio Ramón MartínCatalina Alarcón de la Lastra
Nov 29, 2013·Journal of Cardiac Surgery·H BombergM D Menger
Aug 1, 2016·Pathology, Research and Practice·Fabricia PetronilhoJoão Batista Teixeira Da Rocha
Oct 18, 2007·Inflammatory Bowel Diseases·Norman R HarrisGeorgia A Morgan
Aug 6, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Mikiji MoriD Neil Granger
Dec 2, 2017·Nutrition Research Reviews·Sandra NunesPaula Silva
Oct 20, 2007·American Journal of Physiology. Gastrointestinal and Liver Physiology·Joel PeterssonLena Holm
Oct 26, 2016·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·R F ClaudinoG A Rae

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.